Envoy Medical, Inc.
COCH
$0.68
$0.000.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.24% | -3.40% | -55.91% | 14.89% | 30.50% |
| Total Depreciation and Amortization | 74.57% | 56.07% | 58.82% | 42.86% | 30.08% |
| Total Amortization of Deferred Charges | -7.93% | -30.83% | -12.27% | 17.43% | 73.92% |
| Total Other Non-Cash Items | 8.22% | 8.80% | 157.34% | -85.92% | -82.69% |
| Change in Net Operating Assets | 388.24% | 113.34% | 143.44% | 151.05% | 35.10% |
| Cash from Operations | -1.40% | 26.65% | 21.61% | 18.22% | -5.02% |
| Capital Expenditure | 81.73% | 134.33% | 91.04% | -332.02% | -540.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 81.73% | 134.33% | 91.04% | -332.02% | -540.52% |
| Total Debt Issued | -50.00% | 0.00% | 114.29% | 81.82% | 100.00% |
| Total Debt Repaid | -1.20% | 25.04% | 19.96% | -8.78% | -62.70% |
| Issuance of Common Stock | 306.53% | 70.42% | -80.80% | -96.48% | 1,501.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 25.62% | -32.79% | -- | -- | -- |
| Other Financing Activities | 25.67% | 254.61% | -84.53% | -84.53% | -84.53% |
| Cash from Financing | -17.65% | 23.49% | -14.90% | -26.92% | -5.09% |
| Foreign Exchange rate Adjustments | 160.00% | 120.00% | 120.00% | 140.00% | -66.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -237.97% | 93.00% | 110.97% | -90.45% | -68.67% |